Life-changing hearing technologies recognized for excellence
SOMERSET, N.J., May 09, 2022-(BUSINESS WIRE)-Hearing aid manufacturer Oticon, Inc. is yet again receiving accolades for innovation in the design and development of hearing aid technology, adding to an already impressive resume of industry honors. Oticon MyMusic has been named a winner of the 2022 MedTech Breakthrough Awards, and Oticon Play PX and the Oticon SmartCharger have been awarded the internationally recognized Red Dot Product Design Award: 2022.
"Whether we’re applying an on-board Deep Neural Network (DNN) to pediatric care or amplifying the music-listening experience for the baby boomer generation, Oticon is continuously finding ways to provide life-changing results to people with hearing loss," said Gary Rosenblum, President of Oticon. "These latest award wins are a testament to the innovation and devotion of the entire Oticon team, as we design and deliver cutting-edge hearing technologies to the millions of people who need them."
A new feature of Oticon More™ hearing aids, Oticon MyMusic delivers crystal-clear sound quality for live and streamed music. Featuring a new amplification strategy and a specially designed music-oriented signal processing program, Oticon MyMusic captures the full dynamics of music, allowing individuals with hearing loss to enjoy all the nuances of their favorite compositions.
Oticon Play PX is the world’s first pediatric hearing aid with an on-board DNN designed to learn and recognize sounds the same way children do – through experience. It gives children with hearing loss a more natural listening experience, allowing them to access more of the important sounds in their environment and unleash the magic of childhood.
The Oticon SmartCharger is a state-of-the-art rechargeable solution that delivers freedom and flexibility for on-the-go hearing aid wearers. The sleek, portable charger delivers a full day of power, including streaming, in just three hours.* With a protective case and a built-in drying function to prevent moisture build-up, the Oticon SmartCharger keeps hearing aids in optimal condition and ready for use.
Including these wins, Oticon has earned four award recognitions in 2022. The company was named a CES 2022 Innovation Awards Honoree for Oticon MyMusic in January – its sixth consecutive recognition by the Consumer Technology Association.
For information about Oticon MyMusic, Oticon Play PX, and SmartCharger, visit Oticon.com.
* Fully charges your miniRITE R hearing aids in three hours or three and a half hours for miniBTE R.
Oticon, Inc. – Life-Changing Technology
Oticon is one of the world’s most innovative hearing device manufacturers, with more than 115 years’ experience in the design and development of hearing aids for adults and children. Our comprehensive portfolio of life-changing technology improves not only the quality of hearing but the overall quality of life for people with hearing loss. Oticon challenges conventions and pushes the limits of technology to bring to market hearing solutions that exceed the needs and expectations of people with hearing loss, so that they can live their lives without limit. Our groundbreaking BrainHearing™ technology is helping to provide better hearing with less effort by giving the brain the clearest, purest sound signals to decode. For more information visit Oticon.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220509005079/en/
Contacts
Denise DiMeglio
Gregory FCA
610-228-2102
[email protected]
On Wall Street, some things never change. High inflation or not, the fact of the matter remains that healthcare stocks are the epitome of risk/reward plays. Why? It comes down to the nature of the industry itself. Healthcare companies are unique in that their financial performances aren’t necessarily the most important piece of the puzzle. Rather, a few key factors like clinical data readouts or regulatory approvals indicate whether or not a particular name will be able to generate sustainable r
Hilary Duff says she tries not to miss her therapy appoints in the same way she wouldn't skip getting her hair done.
BEIJING/LONDON (Reuters) -General Electric's healthcare unit said on Tuesday it had increased output of dye used for medical scans and tests at its factory in Ireland and shipped products by air to help combat shortages caused by the suspension of its Shanghai factory. Some of the largest U.S. hospitals said on Tuesday they are facing critical shortages of iodinated contrast media products. The Cleveland Clinic in Ohio; Kaiser Permanente in Oakland, California, Rochester, Minnesota-based Mayo Clinic, and Providence in Renton, Washington all said in statements they were taking steps to secure as much supply as possible and conserve use.
An American-born mom living in Germany is calling out U.S. policies that make it harder to be a parent.
A group of former heads of state led by Gordon Brown, former U.K. Prime Minister, is calling on the U.S. to commit $5 billion to the effort to combat the pandemic globally and urging President Joe Biden to take a more forceful role at a COVID-19 summit planned for Thursday.
Dye & Durham ("Dye & Durham" or the "Company") (TSX: DND), a leading provider of cloud-based software and technology solutions designed to improve efficiency and increase productivity for legal and business professionals, will be the Lead Sponsor for the Women's Health Golf Classic in support of Sunnybrook's Odette Cancer Centre, taking place on May 30 at the Granite Golf Club in Stouffville, ON.
When will the market turmoil end? Unfortunately, no one really knows. There's no end in sight right now to high inflation, rising interest rates, and the continuing conflict in Ukraine. All of these factors are weighing on the stock market.
As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug.
Several companies, including Yelp Inc, Citigroup, Levi Strauss & Co, and Amazon.com Inc, have already pledged to cover costs for American employees who need to travel out of state for an abortion. Some major employers, such as Walmart Inc and Target Corp, have not weighed in since the leak to Politico last week of a Supreme Court draft opinion that would overturn its 1973 decision legalizing abortion nationwide.
Health experts expect the new subvariant to become the dominant strain of COVID-19 in the United States in the next few weeks
The move to acquire the New Haven, Conn., biopharmaceutical company will give the New York drugmaker full ownership of the Nurtec migraine franchise.
A California woman died six years ago after giving birth to her baby boy in one of the top hospitals in the nation. Her family […]
A political storm over abortion rights in the U.S. has reignited focus on child-care in the country.
Casey’s father is the namesake behind Planned Parenthood v Casey, the 1993 Supreme Court decision that reaffirmed the constitutional right to an abortion
If Roe v. Wade is overturned , states may enact bans on abortion.
Some are concerned that its plant-based estrogens may cause problems. Here’s what the science says.By Sally WadykaTofu, a staple in most Asian cultures, is a plant protein made from soybeans. The…
It was developed to ensure soldiers stayed alert and didn't make mistakes due to tiredness
Seagen CEO Clay Siegall was placed on leave after a domestic abuse allegation, the biotech company said Monday as SGEN stock dropped.
Since the start of the COVID-19 pandemic, a number of new variants have caused surges in infections around the world. Now subvariants BA.4 and BA.5 are driving up cases in South Africa, and could lead to a spike in the US. "The BA.4 and BA.5 sub-variants were identified because South Africa is still doing the vital genetic sequencing that many other countries have stopped doing," says Director General of the World Health Organization Tedros Adhanom Ghebreyesus. "In many countries we're essential
"It is sad to see the flu's impact on all birds," said Jack Davis, Pulitzer Prize winner and author of a new book on bald eagles. What's killing them?
